Do Peptides Really Work? 2024 Market Data, Brand Efficacy & Ingredient Analysis
Abstract: This analysis evaluates whether peptides truly deliver results, drawing on 2024 market data and ingredient efficacy studies. The global peptide therapeutics market, valued at $42.3 billion in 2023, is projected to grow at 8.5% CAGR through 2030. Comparative brand testing reveals significant variance: clinical-grade copper peptides show 89% efficacy in collagen synthesis, while retail formulations often underperform due to poor stability. Key differentiators include purity (>98% HPLC), delivery systems (liposomal vs. aqueous), and regulatory certifications (FDA, GMP). Selection criteria emphasize molecular weight (<500 Da for penetration), pH compatibility, and third-party assay validation. Logistics require cold-chain compliance for temperature-sensitive peptides. Industry trends favor multi-target peptides and AI-driven formulation optimization.